The Correlation between the First Trimester Combined Test Results and Thyroid Stimulating Hormone Levels as well as Its Effect on Pregnancy Outcomes
Abstract
Background: Determining the pregnancy outcomes with independent prognostic factors in the first trimester combined screening test and thyroid stimulating hormone (TSH) is a concern for practitioners. We aimed to evaluate the correlation between TSH and first trimester combined screening test levels and examine their effects on pregnancy outcomes in healthy pregnant women.
Methods: A total of 349 pregnant women in Izmir Ataturk Training and Research Hospital,Turkey with normal TSH values in the first trimester between 2015 and 2020 were enrolled. Patients were divided into two groups as 274 and 75 patients according to TSH values with 2,5 as cut-off value; their birth weights and weeks were compared. Patients were also divided into three groups according to gestational weeks; their TSH values and combined tests were compared.
Results: When grouped based on the TSH threshold value (2.5uIU/ml), no significant relationship was found between the combined test parameters and TSH levels. In the combined test, after grouping according to the week of gestation, a negative correlation was observed between free beta-human chorionic gonadotropin (β-hCG) and TSH measured at 11 weeks (P=0.040, r=-0.189). A significant negative correlation was found between free β-hCG and newborn birth weight (P=0.032, r=-0.199), TSH and delivery time (P=0.011, r=-0.235).
Conclusion: Free β-hCG and TSH levels could guide practitioners for birth weight and early delivery, respectively. Postponing the combined test for patients with elevated serum TSH levels to between the 12th and 13th weeks of gestation may reduce false positives.
2. Shields BM, Knight BA, Hill A, Hattersley AT, Vaidya B (2011). Fetal thyroid hormone level at birth is associated with fetal growth. J Clin Endocrinol Metab, 96: E934–E938.
3. Koller-Smith LI, Shah PS, Ye XY, et al (2017). Comparing very low birth weight versus very low gestation cohort methods for outcome analysis of high-risk preterm infants. BMC Pediatr, 17:166.
4. Monen L, Kuppens SM, Hasaart TH, et al (2015). Maternal thyrotropin is independently related to small for gestational age neonates at term. Clin Endocrinol (Oxf), 82:254–259.
5. Nishioka E, Hirayama S, Ueno T, et al (2015). Relationship between maternal thyroid-stimulating hormone (TSH) elevation during pregnancy and low birth weight: a longitudinal study of apparently healthy urban Japanese women at very low risk. Early Hum Dev, 91:181–185.
6. Hershman JM (2004 Jun). Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab, 18(2):249-65.
7. Dugoff L, Hobbins JC, Malone FD, et al (2004). First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol, 191:1446-51.
8. Lawrence JB, Oxvig C, Overgaard MT, et al (1999). The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A, 96:3149-53.
9. Barrett SL, Bower C, Hadlow NC (2008). Use of the combined first-trimester screen result and low PAPP-A to predict the risk of adverse fetal outcomes. Prenat Diagn, 28:28-35.
10. Spencer CA, Allen VM, Flowerdew G, et al (2008). Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes. Prenat Diagn, 28:1029-36.
11. Royal College of Obstetricians and Gynaecologists. The Investigation and Management of the Small for Gestational Age Fetus Green-top Guideline NO. 31 [Internet]. RCOG, 2014 [updated Feb 2014; cited Jan 2013]. Available from https://www.rcog.org.uk/media/t3lmjhnl/gtg_31.pdf
12. Örgül G, Doğan R, Portakal O, Beksaç MS (2018). Relationship between first-trimester maternal TSH levels and Down syndrome screening tests. Cukurova Med J, 43:94-99.
13. Aytan H, Caliskan AC, Demirturk F, Sahin S, Erdogan F, Kuzu Z (2013). Relationship between maternal thyroid hormones and the biochemical markers of the first-trimester aneuploidy screening. Arch Gynecol Obstet, 287:1125–1129.
14. Zhang C, Yang X, Zhang Y, et al (2019). Association Between Maternal Thyroid Hormones and Birth Weight at Early and Late Pregnancy. J Clin Endocrinol Metab, 104:5853–5863.
15. Karagiannis G, Ashoor G, Maiz N, Jawdat F, Nicolaides KH (2011). Maternal thy-roid function at eleven to thirteen weeks of gestation and subsequent delivery of small for gestational age neonates. Thy-roid, 21:1127–1131.
16. Lee SY, Cabral HJ, Aschengrau A, Pearce EN (2020). Associations Between Maternal Thyroid Function in Pregnancy and Obstetric and Perinatal Outcomes. J Clin Endocrinol Metab,105:e2015-e2023.
17. Sirikunalai P, Wanapirak C, Sirichotiyakul S, et al (2016). Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes. J Obstet Gynaecol,36:178-182.
18. Bilagi A, Burke DL, Riley RD, Mills I, Kilby MD, Katie Morris R (2017). Association of maternal serum PAPP-A levels, nuchal translucency and crown-rump length in first trimester with adverse pregnancy outcomes: retrospective cohort study. Prenat Diagn,37:705-711.
19. Prior T, Mullins E, Bennett P, Kumar S (2014). Are 1st-trimester β-human chori-onic gonadotrophin and pregnancy-associated plasma protein A levels predic-tive of intrapartum fetal compromise in a selected normal population?. Aust N Z J Obstet Gynaecol;54:418-423.
20. Morris RK, Bilagi A, Devani P, Kilby MD (2017).Association of serum PAPP-A lev-els in the first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis. Prenat Diagn,37:253-265.
21. Caballero Sanz S, Nozaleda Pastor G, Gar-cia-Tizon Larroca S (2018). First-Trimester Biochemical Screening For Low Birth Weight: Clinical Effectiveness of Low Pregnancy-Associated Plasma Protein-A and High Thyroid-Stimulating Hormone. Clin Lab,64:1501-1508.
| Files | ||
| Issue | Vol 52 No 4 (2023) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v52i4.12437 | |
| Keywords | ||
| Thyroid stimulating hormone Combined test Newborn birth weight | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
